Bentham Science Logo

Recent Patents on Anti-Cancer Drug Discovery

Volume 14, 4 Issues, 2019
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery

,

Volume 14

-

Number 1



Biography   Open Access



Commentary   Open Access



Review Article   Open Access

Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827


Review Article   Open Access



Review Article   Open Access



Review Article   Open Access

Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

, 14(1): 39 - 52

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*


DOI: 10.2174/1574892814666190102122848


Review Article   Open Access



Review Article   Open Access



Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Editor's Choice

Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827



PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256







Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents

, 2017; 12(3): 190 - 207

Stephanie Lucas, Claire Soave, Ghazal Nabil, Zainab Sabry Othman Ahmed, Guohua Chen, Hossny Awad El-Banna, Q. Ping Dou* and Jian Wang*


DOI: 10.2174/1574892812666170619125503





Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent

, 2017; 12(2): 174 - 185

Shirin Mollazadeh, Jamal Shamsara, Maryam Iman* and Farzin Hadizadeh*


DOI: 10.2174/1574892812666170126162521



Open Access Articles

From Antimicrobial to Anticancer Peptides: The Transformation of Peptides

, 2019; 14(1): 70 - 84

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*





New Anti-Cancer Strategies in Testicular Germ Cell Tumors

, 2019; 14(1): 53 - 59

Paolo Chieffi*, Marco De Martino and Francesco Esposito




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*




Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

, 2019; 14(1): 39 - 52

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*




Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment

, 2019; 14(1): 32 - 38

Giorgia Scarpellino, Tullio Genova and Luca Munaron*




Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds

, 2019; 14(1): 19 - 31

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*




Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 2018; 13(4): 469 - 472

Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*





Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature

, 2018; 13(4): 422 - 427

Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*




Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

, 2018; 13(2): 209 - 223

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*




Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*




PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145 - 158

Kristin N. Taylor and Ramez N. Eskander*






Most Cited Articles

Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far

, 2016; 11(1): 67-97.

Devivasha Bordoloi, Nand K. Roy, Javadi Monisha, Ganesan Padmavathi and Ajaikumar B. Kunnumakkara


DOI: 10.2174/1574892810666151020101706


Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

, 2016; 11(2): 184-196.

Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian Luo


DOI: 10.2174/1574892811888160304113346



Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses

, 2016; 11(1): 121-133.

Amr Amin, Alaaeldin A. Hamza, Sayel Daoud, Kamal Khazanehdari, Ala’a Al Hrout, Badriya Baig, Amphun Chaiboonchoe, Thomas E. Adrian, Nazar Zaki and Kourosh Salehi-Ashtiani


DOI: 10.2174/1574892810666151102110248


Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process

, 2016; 11(2): 236-244.

Kundong Zhang, Guang Yang, Weidong Wu, Jing Zhang, Xiang Xia, Tao Jiang, Jun Cao, Kejan Huang, Zhengjun Qiu and Chen Huang


DOI: 10.2174/1574892811666160128151437




Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells

, 2016; 11(2): 215-227.

Yanming Wang, Jun Ma, Xinyan Yan, Xiaoyu Chen, Lingling Si, Ying Liu, Jichun Han, Wenjin Hao and Qiusheng Zheng


DOI: 10.2174/1573406412666160307151904


Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy

, 2016; 11(3): 275-282.

Giovanni Vitale, Alessandra Dicitore, Erika Messina, Concetta Sciammarella, Antongiulio Faggiano and Annamaria Colao


DOI: 10.2174/1574892811666160614115356


Anti-EGFR Therapy: Strategies in Head and Neck Squamous Cell Carcinoma

, 2016; 11(2): 170-183.

Renato J. Oliveira-Silva, Ana Carolina de Carvalho, Luciano de Souza Viana, Andre L. Carvalho and Rui M. Reis


DOI: 10.2174/1574892811666160309121238



Most Accessed Articles

Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86-105.

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*


DOI: 10.2174/1574892812666171108124218


Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211



PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392-410.

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256







Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment

, 2014; 9(2): 153-175.

Jo-Anne de la Mare, Lara Contu, Morgan C. Hunter, Buhle Moyo, Jason N. Sterrenberg, Karim C.H. Dhanani, Lorraine Z. Mutsvunguma and Adrienne L. Edkins


DOI: 10.2174/15748928113086660046



Related Journals

Related eBooks

eBooks Catalog